Our spring 2024 edition is now out! We spotlight how we are keeping infants, children and young people safe as they access health services. Plus a welcome return of our regular “Starter for Ten” and “Day In The Life” features.
Whether you're a trainee, SAS doctor or consultant, explore our current volunteering opportunities: a new Officer for Ireland and International Officer, plus roles in supporting training, invited reviews and more.
Packed with top tips and resources from paediatricians of all levels, plus how to take advantage of free RCPCH membership as a medical student or foundation doctor. #ChoosePaediatrics
2023 was a challenging year in medicine, but we worked alongside you, our members, on some huge achievements, from the new training curriculum, Progress+ to our campaign on youth vaping.
Our new 'hub' helps specialty groups develop a guideline for RCPCH endorsement - including running the search, formulating the recommendations and consulting with stakeholders.
Let's work together to make sure children are as safe as they can be from these potentially serious illnesses. We invite you to download our poster and to talk with families about immunisations.
Childhood mental health problems are common and increasing across the UK. We outline the role for paediatricians in prevention, early recognition and holistic care, and we call for greater investment.
Dr Emily Parker is one of our new Clinical Fellows with the Clean Air Fund Partnership, and in her first blog, she describes how doctors are taking a more critical look at the impact of air pollution on children's health.
We've refreshed the RCPCH manifesto to support children’s health and wellbeing in a changing world - underpinned by seven pillars from prioritising child health services to tackling climate change.
Steve says, "I am committed to working with members and College staff in advocating for paediatricians and children at every given opportunity, across the UK and around the world."
More than 2,000 healthcare professionals signed our open letter, which urges the Government to implement an immunisation programme for this common but sometimes fatal respiratory virus.
On 19 October 2022 Dr Bill Kirkup CBE published the findings of the Independent Investigation into East Kent Maternity Services in his report Reading the signals: Maternity and neonatal services in East Kent.
Following recent observations of a sustained rise in rates of infections of Respiratory Syncytial Virus (RSV), it has been recommended that the palivizumab passive immunisation programme recommences.
Dr Patricia Jackson, a RCPCH Fellow based in Edinburgh, looks back on International Fetal Alcohol Spectrum Disorders Awareness Day, which was on 9 September. She shares, from a personal perspective, information gained on how paediatricians can become more aware of and make a diagnosis of FASD.
As RCPCH celebrates its 25th birthday, 25 members have shared stories about a case that stayed with them. These stories will be published throughout 2021.
The Neonatal and Paediatric Pharmacy Group (NPPG), with support from the Royal College of Paediatrics of Child Health (RCPCH) has produced a proposal for a national approach for standardised intravenous infusion concentrations in children.
What can we learn from each other? Dr Siân Ludman, consultant paediatric allergist, and her trainee and consultant colleagues have developed a new guide for those supervising trainees in paediatric allergy, immunology and infectious diseases. An achievement to be proud of – and she hopes it inspires...
After 31 years of dedicated service as the British Paediatric Surveillance Unit’s (BPSU) Scientific Coordinator, Richard Lynn will be leaving the BPSU at the end of March. Richard’s unparalleled commitment to the BPSU and rare disease epidemiology has been integral to the Unit’s continued success.
Ranitidine products (Brand names including Zantac®) were voluntarily withdrawn by manufacturers in October 2019 due to the presence of low levels of an impurity called NDMA. The European Medicines Agency has since confirmed its recommendation to suspend all ranitidine medicines in the EU.